ArticleBlood research2015

Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin.

Hee Kyung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.